Skip to Content
You are currently on the new version of our website. Access the old version .

Most Viewed

  • Review
  • Open Access
77 Citations
250,851 Views
22 Pages

IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein

  • Vladimir N. Uversky,
  • Elrashdy M. Redwan,
  • William Makis and
  • Alberto Rubio-Casillas

Less than a year after the global emergence of the coronavirus SARS-CoV-2, a novel vaccine platform based on mRNA technology was introduced to the market. Globally, around 13.38 billion COVID-19 vaccine doses of diverse platforms have been administer...

  • Case Report
  • Open Access
17 Citations
118,203 Views
8 Pages

An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer

  • Dubravko Forčić,
  • Karmen Mršić,
  • Melita Perić-Balja,
  • Tihana Kurtović,
  • Snježana Ramić,
  • Tajana Silovski,
  • Ivo Pedišić,
  • Ivan Milas and
  • Beata Halassy

23 August 2024

Intratumoural oncolytic virotherapy may have promise as a means to debulk and downstage inoperable tumours in preparation for successful surgery. Here, we describe the unique case of a 50-year-old self-experimenting female virologist with locally rec...

  • Article
  • Open Access
1 Citations
74,278 Views
16 Pages

Impact of mRNA and Inactivated COVID-19 Vaccines on Ovarian Reserve

  • Enes Karaman,
  • Adem Yavuz,
  • Erol Karakas,
  • Esra Balcioglu,
  • Busra Karaca,
  • Hande Nur Doganay,
  • Koray Gorkem Sacinti and
  • Orhan Yildiz

24 March 2025

Objectives: This study aimed to elucidate the effects of messenger RNA (mRNA) and inactivated coronavirus disease 2019 (COVID-19) vaccines on ovarian histology and reserve in rats. Methods: Thirty female Wistar albino rats, aged 16–24 weeks, we...

  • Article
  • Open Access
17 Citations
50,176 Views
16 Pages

Chronic Fatigue and Dysautonomia following COVID-19 Vaccination Is Distinguished from Normal Vaccination Response by Altered Blood Markers

  • Amelie Semmler,
  • Anna Katharina Mundorf,
  • Anna Sabrina Kuechler,
  • Karin Schulze-Bosse,
  • Harald Heidecke,
  • Kai Schulze-Forster,
  • Matthias Schott,
  • Markus Uhrberg,
  • Sandra Weinhold and
  • Jana Ruhrländer
  • + 4 authors

26 October 2023

SARS-CoV-2 mRNA vaccination can entail chronic fatigue/dysautonomia tentatively termed post-acute COVID-19 vaccination syndrome (PACVS). We explored receptor autoantibodies and interleukin-6 (IL-6) as somatic correlates of PACVS. Blood markers determ...

  • Article
  • Open Access
6 Citations
46,295 Views
17 Pages

NEURO-COVAX: An Italian Population-Based Study of Neurological Complications after COVID-19 Vaccinations

  • Maria Salsone,
  • Carlo Signorelli,
  • Alessandro Oldani,
  • Valerio Fabio Alberti,
  • Vincenza Castronovo,
  • Salvatore Mazzitelli,
  • Massimo Minerva and
  • Luigi Ferini-Strambi

21 October 2023

Objective: In this Italian population-based study, we aimed to evaluate the neurological complications after the first and/or second dose of COVID-19 vaccines and factors potentially associated with these adverse effects. Methods: Our study included...

  • Perspective
  • Open Access
6 Citations
43,438 Views
9 Pages

14 November 2024

The action of mRNA-based vaccines requires the expression of the antigen in cells targeted by lipid nanoparticle–mRNA complexes. When the vaccine antigen is not fully retained by the producer cells, its local and systemic diffusion can have con...

  • Case Report
  • Open Access
2 Citations
37,289 Views
10 Pages

Fatal Myocarditis following COVID-19 mRNA Immunization: A Case Report and Differential Diagnosis Review

  • Pedro Manuel Barros de Sousa,
  • Elon Almeida Silva,
  • Marcos Adriano Garcia Campos,
  • Joyce Santos Lages,
  • Rita da Graça Carvalhal Frazão Corrêa and
  • Gyl Eanes Barros Silva

13 February 2024

Carditis in childhood is a rare disease with several etiologies. We report a case of infant death due to pericarditis and myocarditis after the mRNA vaccine against COVID-19 (COVIDmRNAV). A 7-year-old male child received the first dose of the COVIDmR...

  • Review
  • Open Access
33 Citations
29,567 Views
26 Pages

Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19

  • Noelia Silva-Pilipich,
  • Uxue Beloki,
  • Laura Salaberry and
  • Cristian Smerdou

17 March 2024

SARS-CoV-2 virus, the causative agent of COVID-19, has produced the largest pandemic in the 21st century, becoming a very serious health problem worldwide. To prevent COVID-19 disease and infection, a large number of vaccines have been developed and...

  • Systematic Review
  • Open Access
48 Citations
27,993 Views
25 Pages

Why Parents Say No to Having Their Children Vaccinated against Measles: A Systematic Review of the Social Determinants of Parental Perceptions on MMR Vaccine Hesitancy

  • M. Lelinneth B. Novilla,
  • Michael C. Goates,
  • Alisha H. Redelfs,
  • Mallory Quenzer,
  • Lynneth Kirsten B. Novilla,
  • Tyler Leffler,
  • Christian A. Holt,
  • Russell B. Doria,
  • Michael T. Dang and
  • Katelyn Aldridge
  • + 3 authors

Ongoing outbreaks of measles threaten its elimination status in the United States. Its resurgence points to lower parental vaccine confidence and local pockets of unvaccinated and undervaccinated individuals. The geographic clustering of hesitancy to...

  • Systematic Review
  • Open Access
16 Citations
25,180 Views
39 Pages

New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review

  • Arvind Nune,
  • Victor Durkowski,
  • S. Sujitha Pillay,
  • Bhupen Barman,
  • Helen Elwell,
  • Kaustubh Bora,
  • Syed Bilgrami,
  • Sajid Mahmood,
  • Nasarulla Babajan and
  • Ciro Manzo
  • + 2 authors

8 October 2023

A comprehensive, up-to-date systematic review (SR) of the new-onset rheumatic immune-mediated inflammatory diseases (R-IMIDs) following COVID-19 vaccinations is lacking. Therefore, we investigated the demographics, management, and prognosis of new R-...

  • Review
  • Open Access
109 Citations
24,980 Views
20 Pages

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

  • Jialiang Wang,
  • Yaopeng Ding,
  • Kellie Chong,
  • Meng Cui,
  • Zeyu Cao,
  • Chenjue Tang,
  • Zhen Tian,
  • Yuping Hu,
  • Yu Zhao and
  • Shaoyi Jiang

8 October 2024

Introduction: The advent of lipid nanoparticles (LNPs) as a delivery platform for mRNA therapeutics has revolutionized the biomedical field, particularly in treating infectious diseases, cancer, genetic disorders, and metabolic diseases. Recent Advan...

  • Review
  • Open Access
20 Citations
23,572 Views
28 Pages

Advances in Poultry Vaccines: Leveraging Biotechnology for Improving Vaccine Development, Stability, and Delivery

  • Khaled Abdelaziz,
  • Yosra A. Helmy,
  • Alexander Yitbarek,
  • Douglas C. Hodgins,
  • Tamer A. Sharafeldin and
  • Mohamed S. H. Selim

28 January 2024

With the rapidly increasing demand for poultry products and the current challenges facing the poultry industry, the application of biotechnology to enhance poultry production has gained growing significance. Biotechnology encompasses all forms of tec...

  • Article
  • Open Access
15 Citations
23,431 Views
18 Pages

Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS)

  • Anna Katharina Mundorf,
  • Amelie Semmler,
  • Harald Heidecke,
  • Matthias Schott,
  • Falk Steffen,
  • Stefan Bittner,
  • Karl J. Lackner,
  • Karin Schulze-Bosse,
  • Marc Pawlitzki and
  • Fritz Boege
  • + 3 authors

18 July 2024

Post-acute COVID-19 vaccination syndrome (PACVS) is a chronic disease triggered by SARS-CoV-2 vaccination (estimated prevalence 0.02%). PACVS is discriminated from the normal post-vaccination state by altered receptor antibodies, most notably angiote...

  • Review
  • Open Access
14 Citations
22,668 Views
28 Pages

31 January 2025

The development of an effective HIV-1 vaccine remains a formidable challenge in biomedical research. Despite significant advancements in our understanding of HIV biology and pathogenesis, progress has been impeded by factors such as the virus's genet...

  • Review
  • Open Access
45 Citations
21,856 Views
16 Pages

Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?

  • Giovanna Milano,
  • Giovanni Guarducci,
  • Nicola Nante,
  • Emanuele Montomoli and
  • Ilaria Manini

4 June 2023

Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three most common sexually transmitted infections (STIs) in both males and females, and the most common viral STI. A crucial public health strategy to protect people a...

  • Review
  • Open Access
82 Citations
21,812 Views
25 Pages

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity

  • Liusheng Wu,
  • Xiaoqiang Li,
  • Xinye Qian,
  • Shuang Wang,
  • Jixian Liu and
  • Jun Yan

12 February 2024

In recent years, lipid nanoparticles (LNPs) have attracted extensive attention in tumor immunotherapy. Targeting immune cells in cancer therapy has become a strategy of great research interest. mRNA vaccines are a potential choice for tumor immunothe...

  • Review
  • Open Access
10 Citations
21,169 Views
17 Pages

Adverse Hematological Effects of COVID-19 Vaccination and Pathomechanisms of Low Acquired Immunity in Patients with Hematological Malignancies

  • Armand N. Yazdani,
  • Nathaniel DeMarco,
  • Parth Patel,
  • Arian Abdi,
  • Prathosh Velpuri,
  • Devendra K. Agrawal and
  • Vikrant Rai

15 March 2023

The SARS-CoV-2 virus and the COVID-19 pandemic have spread across the world and severely impacted patients living with hematological conditions. Immunocompromised patients experience rapidly progressing symptoms following COVID-19 infection and are a...

  • Systematic Review
  • Open Access
1 Citations
21,113 Views
30 Pages

Following mass vaccinations for the control of the COVID-19 epidemic, a spectrum of cardiac and neurological disorders was reported among vaccinated individuals. This study examined the range of complications documented and factors related to their o...

  • Review
  • Open Access
53 Citations
20,883 Views
37 Pages

Vaccine Strategies to Elicit Mucosal Immunity

  • Yufeng Song,
  • Frances Mehl and
  • Steven L. Zeichner

13 February 2024

Vaccines are essential tools to prevent infection and control transmission of infectious diseases that threaten public health. Most infectious agents enter their hosts across mucosal surfaces, which make up key first lines of host defense against pat...

  • Review
  • Open Access
114 Citations
19,956 Views
18 Pages

Recent Advances in the Lipid Nanoparticle-Mediated Delivery of mRNA Vaccines

  • K. Swetha,
  • Niranjan G. Kotla,
  • Lakshmi Tunki,
  • Arya Jayaraj,
  • Suresh K. Bhargava,
  • Haitao Hu,
  • Srinivasa Reddy Bonam and
  • Rajendra Kurapati

14 March 2023

Lipid nanoparticles (LNPs) have recently emerged as one of the most advanced technologies for the highly efficient in vivo delivery of exogenous mRNA, particularly for COVID-19 vaccine delivery. LNPs comprise four different lipids: ionizable lipids,...

  • Review
  • Open Access
32 Citations
19,953 Views
38 Pages

Human Tick-Borne Diseases and Advances in Anti-Tick Vaccine Approaches: A Comprehensive Review

  • Marie-Edith Nepveu-Traversy,
  • Hugues Fausther-Bovendo and
  • George (Giorgi) Babuadze

29 January 2024

This comprehensive review explores the field of anti-tick vaccines, addressing their significance in combating tick-borne diseases of public health concern. The main objectives are to provide a brief epidemiology of diseases affecting humans and a th...

  • Review
  • Open Access
20 Citations
19,499 Views
27 Pages

18 January 2024

Respiratory Syncytial Virus (RSV) poses a significant global health concern as a major cause of lower respiratory tract infections (LRTIs). Over the last few years, substantial efforts have been directed towards developing vaccines and therapeutics t...

  • Review
  • Open Access
123 Citations
19,349 Views
34 Pages

An Overview of the Public Health Challenges in Diagnosing and Controlling Human Foodborne Pathogens

  • Ayman Elbehiry,
  • Adil Abalkhail,
  • Eman Marzouk,
  • Ahmed Elnadif Elmanssury,
  • Abdulaziz M. Almuzaini,
  • Hani Alfheeaid,
  • Mohammed T. Alshahrani,
  • Nasser Huraysh,
  • Mai Ibrahem and
  • Akram Abu-Okail
  • + 6 authors

24 March 2023

Pathogens found in food are believed to be the leading cause of foodborne illnesses; and they are considered a serious problem with global ramifications. During the last few decades, a lot of attention has been paid to determining the microorganisms...

  • Review
  • Open Access
35 Citations
19,127 Views
28 Pages

Developments in Rabies Vaccines: The Path Traversed from Pasteur to the Modern Era of Immunization

  • Krithiga Natesan,
  • Shrikrishna Isloor,
  • Balamurugan Vinayagamurthy,
  • Sharada Ramakrishnaiah,
  • Rathnamma Doddamane and
  • Anthony R. Fooks

29 March 2023

Rabies is a disease of antiquity and has a history spanning millennia ever since the first interactions between humans and dogs. The alarming fatalities caused by this disease have triggered rabies prevention strategies since the first century BC. Th...

  • Review
  • Open Access
57 Citations
19,109 Views
14 Pages

Immunosenescence: Aging and Immune System Decline

  • Priyanka Goyani,
  • Rafail Christodoulou and
  • Evros Vassiliou

23 November 2024

Immunosenescence, a systematic reduction in the immune system connected with age, profoundly affects the health and well-being of elderly individuals. This review outlines the hallmark features of immunosenescence, including thymic involution, inflam...

  • Review
  • Open Access
7 Citations
18,959 Views
14 Pages

COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?

  • Wing-Yin Leung,
  • Henry H. L. Wu,
  • Lauren Floyd,
  • Arvind Ponnusamy and
  • Rajkumar Chinnadurai

24 June 2023

Amyloidosis is a complex disorder characterized by deposited insoluble fibrillar proteins which misfold into β-pleated sheets. The pathogenesis of amyloidosis can vary but can be the result of immune dysregulation that occurs from sustained high...

  • Systematic Review
  • Open Access
18 Citations
18,611 Views
17 Pages

15 March 2023

Coronavirus disease 2019 (COVID-19) vaccine has effectively suppressed the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and alleviated its symptoms, but there are also many adverse events. Joint diseases caused by COVID-...

  • Review
  • Open Access
17 Citations
18,096 Views
17 Pages

28 February 2024

Herpes zoster, induced by the reactivation of the varicella-zoster virus (VZV), is a unilaterally distributed vesicular rash that can cause multiple complications. VZV not only causes neurological problems, including postherpetic neuralgia and ocular...

  • Systematic Review
  • Open Access
30 Citations
17,879 Views
19 Pages

Human papillomavirus (HPV) vaccination has revolutionized cervical cancer prevention. Clinical trials confirm that the quadrivalent (HPV types 6, 11, 16, 18) and bivalent (HPV types 16, 18) vaccines effectively prevent HPV infections and cervical neo...

  • Article
  • Open Access
9 Citations
17,825 Views
17 Pages

COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up

  • Annalisa Rosso,
  • Maria Elena Flacco,
  • Graziella Soldato,
  • Giuseppe Di Martino,
  • Cecilia Acuti Martellucci,
  • Roberto Carota,
  • Marco De Benedictis,
  • Graziano Di Marco,
  • Rossano Di Luzio and
  • Lamberto Manzoli
  • + 2 authors

4 August 2023

We carried out a cohort study on the overall population of the province of Pescara, Italy, to assess the real-world effectiveness of SARS-CoV-2 vaccination against infection, severe, or lethal COVID-19, two years after the start of the vaccination ca...

  • Review
  • Open Access
37 Citations
17,604 Views
27 Pages

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events

  • Girolamo Giannotta,
  • Antonio Murrone and
  • Nicola Giannotta

28 March 2023

Each injection of any known vaccine results in a strong expression of pro-inflammatory cytokines. This is the result of the innate immune system activation, without which no adaptive response to the injection of vaccines is possible. Unfortunately, t...

  • Article
  • Open Access
17,535 Views
15 Pages

30 September 2025

Introduction: Vaccines are the most widely used public health measure to control the global COVID-19 pandemic. Most vaccines used in Europe and North America are mRNA-based. A mass vaccination campaign was carried out between 2021 and 2024. Some adve...

  • Review
  • Open Access
49 Citations
16,901 Views
48 Pages

Immune Control of Avian Influenza Virus Infection and Its Vaccine Development

  • Piyush Dey,
  • Akanksha Ahuja,
  • Jaishal Panwar,
  • Poonam Choudhary,
  • Shital Rani,
  • Mandeep Kaur,
  • Akanksha Sharma,
  • Jatinder Kaur,
  • Ashok Kumar Yadav and
  • Ravi Pratap Barnwal
  • + 4 authors

4 March 2023

The avian influenza A virus (AIV) is naturally prevalent in aquatic birds, infecting different avian species and transmitting from birds to humans. Both AIVs, the H5N1 and H7N9 viruses, have the potential to infect humans, causing an acute influenza...

  • Review
  • Open Access
62 Citations
16,726 Views
36 Pages

9 March 2024

Annually, more than 1.5 million preventable new hepatitis B (HBV) infections continue to occur, with an estimated global burden of 296 million individuals living with chronic hepatitis B infection. This substantial health challenge results in over 82...

  • Review
  • Open Access
56 Citations
16,524 Views
25 Pages

Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines

  • Kumar Saurabh Srivastava,
  • Vandana Jeswani,
  • Nabanita Pal,
  • Babita Bohra,
  • Vaishali Vishwakarma,
  • Atharva Ashish Bapat,
  • Yamini Prashanti Patnaik,
  • Navin Khanna and
  • Rahul Shukla

27 March 2023

Japanese encephalitis virus (JEV) is the causal agent behind Japanese encephalitis (JE), a potentially severe brain infection that spreads through mosquito bites. JE is predominant over the Asia-Pacific Region and has the potential to spread globally...

  • Article
  • Open Access
18 Citations
16,306 Views
14 Pages

Vaccines Alone Cannot Slow the Evolution of SARS-CoV-2

  • Debra Van Egeren,
  • Madison Stoddard,
  • Laura F. White,
  • Natasha S. Hochberg,
  • Michael S. Rogers,
  • Bruce Zetter,
  • Diane Joseph-McCarthy and
  • Arijit Chakravarty

16 April 2023

The rapid emergence of immune-evading viral variants of SARS-CoV-2 calls into question the practicality of a vaccine-only public-health strategy for managing the ongoing COVID-19 pandemic. It has been suggested that widespread vaccination is necessar...

  • Article
  • Open Access
70 Citations
15,928 Views
12 Pages

Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study

  • Guillermo Ezpeleta,
  • Ana Navascués,
  • Natividad Viguria,
  • Mercedes Herranz-Aguirre,
  • Sergio Enrique Juan Belloc,
  • Juan Gimeno Ballester,
  • Juan Carlos Muruzábal,
  • Manuel García-Cenoz,
  • Camino Trobajo-Sanmartín and
  • Jesús Castilla
  • + 6 authors

4 April 2024

Respiratory syncytial virus (RSV) infection is a frequent cause of hospitalisation in the first few months of life; however, this risk rapidly decreases with age. Nirsevimab immunoprophylaxis was approved in the European Union for the prevention of R...

  • Review
  • Open Access
20 Citations
15,907 Views
20 Pages

5 March 2024

Group A Streptococcus (GAS), or Streptococcus pyogenes, is a gram-positive bacterium that extensively colonises within the human host. GAS is responsible for causing a range of human infections, such as pharyngitis, impetigo, scarlet fever, septicemi...

  • Review
  • Open Access
1 Citations
15,664 Views
19 Pages

Cardiopulmonary Effects of COVID-19 Vaccination: A Comprehensive Narrative Review

  • Lauren T. Forchette,
  • Luis Palma,
  • Christian Sanchez,
  • Rebecca M. Gibons,
  • Christoph A. Stephenson-Moe and
  • Benjamin J. Behers

Coronavirus disease 2019 (COVID-19) messenger RNA (mRNA) vaccines have been associated with numerous side effects since their widespread release to the public. Cardiovascular complications include myocarditis and pericarditis, Takotsubo cardiomyopath...

  • Article
  • Open Access
13 Citations
15,304 Views
10 Pages

An Oral Galectin Inhibitor in COVID-19—A Phase II Randomized Controlled Trial

  • Alben Sigamani,
  • Kevin H. Mayo,
  • Michelle C. Miller,
  • Hana Chen-Walden,
  • Surendar Reddy and
  • David Platt

25 March 2023

Background: SARS-CoV-2 vaccines play an important role in reducing disease severity, hospitalization, and death, although they failed to prevent the transmission of SARS-CoV-2 variants. Therefore, an effective inhibitor of galectin-3 (Gal-3) could be...

  • Review
  • Open Access
9 Citations
15,055 Views
18 Pages

Basic Properties and Development Status of Aluminum Adjuvants Used for Vaccines

  • Jingyang Lan,
  • Disong Feng,
  • Xueshan He,
  • Qianru Zhang and
  • Rong Zhang

18 October 2024

Background: Aluminum adjuvants, renowned for their safety and efficacy, act as excellent adsorbents and vaccine immunogen enhancers, significantly contributing to innate, endogenous, and humoral immunity. An ideal adjuvant not only boosts the immune...

  • Article
  • Open Access
31 Citations
14,905 Views
20 Pages

2 March 2023

Dengue represents a major public health concern. With effective vaccines in development, it is important to identify motivational factors to maximize dengue vaccine uptake. A cross-sectional, quantitative, electronic survey was administered to a nati...

  • Review
  • Open Access
29 Citations
14,382 Views
26 Pages

Noroviruses: Evolutionary Dynamics, Epidemiology, Pathogenesis, and Vaccine Advances—A Comprehensive Review

  • Cornelius Arome Omatola,
  • Philip Paul Mshelbwala,
  • Martin-Luther Oseni Okolo,
  • Anyebe Bernard Onoja,
  • Joseph Oyiguh Abraham,
  • David Moses Adaji,
  • Sunday Ocholi Samson,
  • Therisa Ojomideju Okeme,
  • Ruth Foluke Aminu and
  • Andrew Musa Adamu
  • + 10 authors

Noroviruses constitute a significant aetiology of sporadic and epidemic gastroenteritis in human hosts worldwide, especially among young children, the elderly, and immunocompromised patients. The low infectious dose of the virus, protracted shedding...

  • Review
  • Open Access
53 Citations
14,095 Views
28 Pages

Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations

  • Sivakumar S. Moni,
  • Siddig Ibrahim Abdelwahab,
  • Aamena Jabeen,
  • Mohamed Eltaib Elmobark,
  • Duaa Aqaili,
  • Gassem Gohal,
  • Bassem Oraibi,
  • Abdulla Mohammed Farasani,
  • Ahmed Ali Jerah and
  • Abdul Majeed Hamad Mohammad Alowayni
  • + 1 author

9 November 2023

Vaccination is a groundbreaking approach in preventing and controlling infectious diseases. However, the effectiveness of vaccines can be greatly enhanced by the inclusion of adjuvants, which are substances that potentiate and modulate the immune res...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X